chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: VARZOS
Symptoms: Facial pain, Gingival pain, Herpes zoster, Pain, Toothache
Clinical narrative: still got the Shingles/ Suspected vaccination failure; Shingles; Tooth ache; Pain; Gum pain; Pain grom cheek to nose; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: still got the Shingles/ Suspected vaccination failure) (serious criteria GSK medically significant), shingles (Verbatim: Shingles), toothache (Verbatim: Tooth ache), pain (Verbatim: Pain), gum pain (Verbatim: Gum pain) and facial pain (Verbatim: Pain grom cheek to nose). The patient was treated with gabapentin. The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported and the outcome of the toothache, pain, gum pain and facial pain were resolved (duration 1 month).   It was unknown if the reporter considered the vaccination failure, shingles, toothache, pain, gum pain and facial pain to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure, shingles, toothache, pain, gum pain and facial pain to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-MAR-2023 This case was reported by a patient via interactive digital media. The patient reported that he or she received Shingles vaccine and still experienced shingles. The patient stated that he or she pray you never had a break out it was the worst pain he or she ever experienced. The patient reported that on last year his or her left gum area felt like a toothache it would start at the top of cheek and go to the nose. The patient went to the dentist and she told him or her had shingles.  The patient stated that he or she was in pain for a month. The diabetic physician gave him or her Gabapentin as a treatment and it was worked. This case was considered as suspected vaccination failure as details regarding completion of primary schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. Follow-up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Vaccination failure
Clinical narrative: still got the Shingles/ Suspected vaccination failure; Shingles; Tooth ache; Pain; Gum pain; Pain grom cheek to nose; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: still got the Shingles/ Suspected vaccination failure) (serious criteria GSK medically significant), shingles (Verbatim: Shingles), toothache (Verbatim: Tooth ache), pain (Verbatim: Pain), gum pain (Verbatim: Gum pain) and facial pain (Verbatim: Pain grom cheek to nose). The patient was treated with gabapentin. The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported and the outcome of the toothache, pain, gum pain and facial pain were resolved (duration 1 month).   It was unknown if the reporter considered the vaccination failure, shingles, toothache, pain, gum pain and facial pain to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure, shingles, toothache, pain, gum pain and facial pain to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-MAR-2023 This case was reported by a patient via interactive digital media. The patient reported that he or she received Shingles vaccine and still experienced shingles. The patient stated that he or she pray you never had a break out it was the worst pain he or she ever experienced. The patient reported that on last year his or her left gum area felt like a toothache it would start at the top of cheek and go to the nose. The patient went to the dentist and she told him or her had shingles.  The patient stated that he or she was in pain for a month. The diabetic physician gave him or her Gabapentin as a treatment and it was worked. This case was considered as suspected vaccination failure as details regarding completion of primary schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. Follow-up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Got shingles vaccine and got shingles/Suspected vaccination failure; Shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in an unspecified number of patients who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patients received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Got shingles vaccine and got shingles/Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-MAR-2023 This case was reported by a patient via interactive digital media. The reporter reported that he or she know the patients who received Shingles vaccine and still experienced shingles. This case was considered as suspected vaccination failure as details regarding completion of primary schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. Follow-up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Near death experience
Clinical narrative: 1st shot almost killed me; This serious case was reported by a consumer via interactive digital media and described the occurrence of near death experience in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced near death experience (Verbatim: 1st shot almost killed me) (serious criteria GSK medically significant and life threatening). The outcome of the near death experience was not reported.   It was unknown if the reporter considered the near death experience to be related to Shingles vaccine.     It was unknown if the company considered the near death experience to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-MAR-2023 This case was reported by a patient via interactive digital media. The patient reported that he or she received first dose of Shingles vaccine and experienced almost killed him or her. Follow-up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Had them twice after the shot /Suspected vaccination failure; Had shingles twice; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Had them twice after the shot /Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Had shingles twice). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-MAR-2023 This case was reported by a patient via interactive digital media. The patient reported that he or she received Shingles vaccine and experienced shingles twice. This case was considered as suspected vaccination failure as details regarding completion of primary schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. Follow-up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS, VARZOS
Symptoms: Herpes zoster, Pain, Vaccination failure
Clinical narrative: Took both doses. Still get little tiny outbreaks/ Suspected vaccination failure; Little tiny outbreaks; Painful; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (Verbatim: Took both doses. Still get little tiny outbreaks/ Suspected vaccination failure) (serious criteria GSK medically significant), shingles (Verbatim: Little tiny outbreaks) and pain (Verbatim: Painful). The outcome of the vaccination failure was unknown and the outcome of the shingles and pain were not resolved.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine and Shingles vaccine.     It was unknown if the company considered the vaccination failure, shingles and pain to be related to Shingles vaccine and Shingles vaccine.   Additional Information: GSK Receipt Date: 31-MAR-2023 This case was reported by a patient via interactive digital media. The patient reported that he or she received both doses of Shingles vaccine and still experienced little tiny outbreaks of shingles. The patient stated that the shingles are still painful. The patient reported that he or she was just grateful that the shingles are not like it used to be his or her outbreak was painful. This case was considered as suspected vaccination failure as details regarding time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. Follow-up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Ended up with shingles even after received vaccine/ suspected vaccination failure; Shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Ended up with shingles even after received vaccine/ suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-APR-2023 This case was reported by a patient via interactive digital media. The patient reported that he or she ended up with shingles even after received Shingles vaccine. The patient stated that hopefully it helps some peoples. This case was considered as suspected vaccination failure as details regarding completion of primary schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. Follow-up would not possible as no contact details were available.
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Got the vaccine still got shingles/suspected vaccination failure; Shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Got the vaccine still got shingles/suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-MAR-2023 This case was reported by a patient relative via interactive digital media. The reporter reported that his or her mother received Shingles vaccine and experienced shingles. This case was considered as suspected vaccination failure as details regarding completion of primary schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. Follow-up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Got the vaccine still got shingles/ suspected vaccine failure; Shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Got the vaccine still got shingles/ suspected vaccine failure) (serious criteria GSK medically significant) and shingles (Verbatim: Shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-MAR-2023 This case was reported by a patient via interactive digital media. The patient reporter reported that he or she received Shingles vaccine and still experienced shingles. This case was considered as suspected vaccination failure as details regarding completion of primary schedule, time to onset for shingles and laboratory confirmation regarding shingles were unknown at the time of reporting. Follow-up would not possible as no contact details were available.
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Developed Shingles within few weeks of vaccination / Suspected vaccination failure; Developed Shingles within few weeks of vaccination; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, several weeks after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Developed Shingles within few weeks of vaccination / Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Developed Shingles within few weeks of vaccination). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-MAR-2023 This case was reported by a patient's relative via interactive digital media. The reporter reported that the her mother in law got the shingles vaccine and developed shingles within a few weeks.   The reporter stated that the vaccine did nothing. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule and laboratory confirmation regarding shingles were unknown at the time of reporting. This case had been linked with US2023AMR067518, reported by same reporter. The follow-up could not be possible as no contact details were available.
Sex: M
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Developed Shingles within few weeks of vaccination / Suspected vaccination failure; Developed Shingles within few weeks of vaccination; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a male patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, several weeks after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Developed Shingles within few weeks of vaccination / Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Developed Shingles within few weeks of vaccination). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-MAR-2023 This case was reported by a patient's related via interactive digital media. The reporter reported that the patient got the shingles vaccine and developed shingles within a few weeks.  The reporter stated that the vaccine did nothing. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule and laboratory confirmation regarding shingles were unknown at the time of reporting. This case had been linked with US2023AMR067517, reported by same reporter. The follow-up could not be possible as no contact details were available.; Sender's Comments:  US-GSK-US2023AMR067517:Same Reporter
Sex: U
Vaccine: VARZOS
Symptoms: Autoimmune disorder
Clinical narrative: Autoimmune disorder; This serious case was reported by a consumer via interactive digital media and described the occurrence of autoimmune disorder in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced autoimmune disorder (Verbatim: Autoimmune disorder) (serious criteria GSK medically significant). The outcome of the autoimmune disorder was not reported.   It was unknown if the reporter considered the autoimmune disorder to be related to Shingles vaccine.   It was unknown if the company considered the autoimmune disorder to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-MAR-2023 This case was reported by a patient via interactive digital media. The patient did shingles vaccine and it gave autoimmune disorder. The reporter stated that do not take shingles vaccine. The reporter further stated that it did work anyway. The follow up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Feeling abnormal, Herpes zoster, Pain, Pruritus, Vaccination failure
Clinical narrative: Painful; Horrible; Itchy spots on my head; Got the shingles / Suspected vaccination failure; Shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. In MAY-2022, several years after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Got the shingles / Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Shingles). On an unknown date, the patient experienced pain (Verbatim: Painful), feels awful (Verbatim: Horrible) and pruritus (Verbatim: Itchy spots on my head). The outcome of the vaccination failure was unknown and the outcome of the shingles and pruritus were not resolved and the outcome of the pain and feels awful were not reported.   It was unknown if the reporter considered the vaccination failure, shingles, pain, feels awful and pruritus to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure, shingles, pain, feels awful and pruritus to be related to Shingles vaccine.   Additional Information: GSK Receipt date: 31-MAR-2023 This case was reported by consumer via  interactive digital media. The reporter reported that he or she received Shingles vaccine and experienced shingles. The reporter reported that now they are stated that it was happen because the vaccine was taken many years ago. The reporter reported that it was painful and horrible and he or she still had itchy spot on his or her head. The reporter stated that he or she had to wait for another year for vaccination because he or she had antibodies. The reporter stated that how about the vaccinating the people at the borders as his or her family had too so many years ago.  The follow-up could not be possible as the as no contact details were available. This case was considered as suspected vaccination failure as details regarding completion of primary vaccination schedule, time to onset and laboratory details were unknown at a time of reporting.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: Vaccine helped lessen the severity/ suspected vaccination failure; Shingles; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On 24-JAN-2023, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Vaccine helped lessen the severity/ suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: Shingles). The outcome of the vaccination failure was unknown and the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-MAR-2023 This case was reported by patient via interactive digital media. The patient was just diagnosed with shingles on the day of reporting (on the post day).  The vaccine helped to lessen the severity. This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. Follow up was not possible, as no contact details were available.
Sex: F
Vaccine: VARZOS
Symptoms: Herpes zoster, Vaccination failure
Clinical narrative: got the vaccine/Suspected vaccination failure; shingles 6 times; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: got the vaccine/Suspected vaccination failure) (serious criteria GSK medically significant) and shingles (Verbatim: shingles 6 times). The outcome of the vaccination failure was unknown and the outcome of the shingles was not reported.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.   It was unknown if the company considered the vaccination failure and shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-MAR-2023 The case was received from the patient's parent via  interactive digital media.  The patient got the vaccine and still had gotten shingles 6 times. The follow-up could not be possible as no contact details were available. This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting.
Sex: U
Vaccine: VARZOS
Symptoms: Pain
Clinical narrative: A little sore; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 06-FEB-2023, the patient received the 2nd dose of Shingles vaccine. In FEB-2023, an unknown time after receiving Shingles vaccine, the patient experienced pain (Verbatim: A little sore). The outcome of the pain was not reported.   It was unknown if the reporter considered the pain to be related to Shingles vaccine.   It was unknown if the company considered the pain to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-MAR-2023 This case was reported by a patient via interactive digital media. The patient just had shingles vaccine the day before reporting. The patient experienced a little sore but not bad. The follow up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Pain
Clinical narrative: it hurt; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   In FEB-2023, the patient received the 1st dose of Shingles vaccine. In FEB-2023, an unknown time after receiving Shingles vaccine, the patient experienced pain (Verbatim: it hurt). The outcome of the pain was not reported.   It was unknown if the reporter considered the pain to be related to Shingles vaccine.   It was unknown if the company considered the pain to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-MAR-2023 This case was reported by patient via interactive digital media. The patient received shingles vaccine this week and it hurt like a son of a gun and he/she was not looking forward to get the second shot of shingles vaccine. The reporter stated that he/she would take it over shingles any day. The follow up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Headache, Herpes zoster, Pain, Vaccination failure
Clinical narrative: Got shot within the year got shingles / Suspected vaccination failure; Got shingles; shooting pain on the right side of my skull; Pain; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 1 year after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: Got shot within the year got shingles / Suspected vaccination failure) (serious criteria GSK medically significant), shingles (Verbatim: Got shingles), headache (Verbatim: shooting pain on the right side of my skull) and pain (Verbatim: Pain). The outcome of the vaccination failure was unknown and the outcome of the shingles, headache and pain were not reported.   The reporter considered the vaccination failure and shingles to be unrelated to Shingles vaccine. It was unknown if the reporter considered the headache and pain to be related to Shingles vaccine.     The company considered the vaccination failure and shingles to be unrelated to Shingles vaccine. It was unknown if the company considered the headache and pain to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-MAR-2023 This case was reported by a patient via interactive digital media. The patient was vaccinated for shingles.  Within the year the patient got shingles and he/she did not believe it was the result of the vaccine. The patient wondered if he/she had a brain tumor being, had shooting pain on the right side of the skull.  The patient honestly did not even need to take Tylenol. The pain was very mild.  The patient suggested to get vaccinated today, and stated it was one of the best things he/she ever did. This case was considered as suspected vaccination failure as details regarding completion of primary schedule and laboratory test confirming shingles were unknown at the time of reporting. Follow-up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: got a severe case of the shingles; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 1 week after receiving Shingles vaccine, the patient experienced shingles (Verbatim: got a severe case of the shingles). The outcome of the shingles was not reported.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.     It was unknown if the company considered the shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-MAR-2023. This case was reported by a patient's friend via interactive digital media. The patient got the shingles vaccine and a week later got a severe case of the shingles. The follow-up could not be possible as no contact details were available. This case has been linked to the case US2023AMR067315 reported by the same reporter; Sender's Comments:  US-GSK-US2023AMR067315:same reporter
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: got a severe case of the shingles; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 1 week after receiving Shingles vaccine, the patient experienced shingles (Verbatim: got a severe case of the shingles). The outcome of the shingles was not reported.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.     It was unknown if the company considered the shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-MAR-2023. This case was reported by a patient's friend via interactive digital media. The patient got the shingles vaccine and a week later got a severe case of the shingles. The follow-up could not be possible as no contact details were available. This case has been linked to the case US2023AMR067279 reported by the same reporter.; Sender's Comments:  US-GSK-US2023AMR067279:same reporter
Sex: U
Vaccine: VARZOS
Symptoms: Arthralgia, Feeling abnormal, Pain in extremity
Clinical narrative: Arm very sore; shoulder very sore; Felt lousy for 1 and 1/2 days after; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of feeling bad in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced feeling bad (Verbatim: Felt lousy for 1 and 1/2 days after), pain in arm (Verbatim: Arm very sore) and shoulder soreness (Verbatim: shoulder very sore). The outcome of the feeling bad was resolved (duration 2 days) and the outcome of the pain in arm and shoulder soreness were not reported.   It was unknown if the reporter considered the feeling bad, pain in arm and shoulder soreness to be related to Shingles vaccine.     It was unknown if the company considered the feeling bad, pain in arm and shoulder soreness to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-MAR-2023. This case was reported by a patient via interactive digital media. The patient just had the second shot of vaccine.  The patient felt lousy for 1 and 1/2 days after.  The patient arm and shoulder very sore. There are other people that took the vaccine shot, did not.  Patient felt lousy for 2 days after the second shot, sore arm and shoulder.  The patient stated that it was so far, so good.  The follow-up could not be possible as no contact details were available.; Sender's Comments:  US-GSK-US2023AMR067347:Same reporter / same product, Invalid case
Sex: U
Vaccine: VARZOS
Symptoms: Illness, Influenza
Clinical narrative: pretty sick/made me sick for 6 weeks; Flu symptoms; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced sickness (Verbatim: pretty sick/made me sick for 6 weeks) and flu symptoms (Verbatim: Flu symptoms). The outcome of the sickness and flu symptoms were resolved (duration 6 weeks).   It was unknown if the reporter considered the sickness and flu symptoms to be related to Shingles vaccine.     It was unknown if the company considered the sickness and flu symptoms to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-MAR-2023 This case was reported by a patient via interactive digital media. The reporter stated that, he/she got the first one and was sick with flu symptoms for at least 3 weeks.  It took another 3 weeks to recover fully. The first shot made him/her sick for 6 weeks.  He/She was dreading the booster but he/she knew how horrific Shingles was and does not wanted to risk getting it. He/She knew that, they could still happen but hopefully it would not.  He/She did not want to risk getting Shingles. The follow up would not possible, as no contact, details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Illness, Pain in extremity
Clinical narrative: Made me sick; Arm hurt; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced sickness (Verbatim: Made me sick) and pain in arm (Verbatim: Arm hurt). The outcome of the sickness was not reported and the outcome of the pain in arm was resolved.   It was unknown if the reporter considered the sickness and pain in arm to be related to Shingles vaccine.     It was unknown if the company considered the sickness and pain in arm to be related to Shingles vaccine.   Additional Information: GSK receipt date: 31-March-2023 This case was reported by a patient via interactive digital media. The patient just received first Shingles shot. The vaccine made patient sick and arm hurt for days, but better than getting shingles. The follow up would not possible, as no contact, details were available.
Sex: U
Vaccine: HEP
Symptoms: Herpes zoster
Clinical narrative: shingles; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of shingles in a elderly patient who received Hepatitis B vaccine for prophylaxis.   On an unknown date, the patient received Hepatitis B vaccine. On an unknown date, an unknown time after receiving Hepatitis B vaccine, the patient experienced shingles (Verbatim: shingles). The outcome of the shingles was not reported.   It was unknown if the reporter considered the shingles to be related to Hepatitis B vaccine.     It was unknown if the company considered the shingles to be related to Hepatitis B vaccine.   Linked case(s) involving the same patient:  US2023AMR067337   Additional Information: GSK receipt date: 31-Mar-2023 The case was received from the patient via interactive digital media. The patient had hepatitis B shots in 90s and gave him or her shingles. As nurse illegible text. The follow-up could not be possible as no contact details were available. The case was linked with case US2023AMR067337, reported by same reporter for different vaccine for same patient.; Sender's Comments:  US-GSK-US2023AMR067337:Same patient, same report, different vaccine
Sex: U
Vaccine: VARZOS
Symptoms: Wheelchair user
Clinical narrative: Shingrix put my bf in a wheel chair for months; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of wheelchair user in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced wheelchair user (Verbatim: Shingrix put my bf in a wheel chair for months). The outcome of the wheelchair user was not reported.   It was unknown if the reporter considered the wheelchair user to be related to Shingrix.     It was unknown if the company considered the wheelchair user to be related to Shingrix.   Additional Information: GSK receipt date: 31-March-2023 This case was reported by a patient via interactive digital media. The reporter's best friend received the Shingrix and put in a wheel chair for months. The patient had right after first and only dose of this poison. The follow up would not possible, as no contact, details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Immediate post-injection reaction, Mobility decreased, Pain, Pain in extremity
Clinical narrative: Arms soreness, hurts to raise arm up; Hurts to raise right arm up; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   In NOV-2022, the patient received the 1st dose of Shingles vaccine (right arm). On an unknown date, immediately after receiving Shingles vaccine, the patient experienced pain in arm (Verbatim: Arms soreness, hurts to raise arm up) and mobility decreased (Verbatim: Hurts to raise right arm up). The patient was treated with ibuprofen and non-drug therapy (Ice Pack (No Medication)). The outcome of the pain in arm was resolving and the outcome of the mobility decreased was not reported.   It was unknown if the reporter considered the pain in arm and mobility decreased to be related to Shingles vaccine.     It was unknown if the company considered the pain in arm and mobility decreased to be related to Shingles vaccine.   Linked case(s) involving the same patient:  US2023AMR067434   Additional Information: GSK Receipt Date: 04-APR-2023 This case was reported by a patient via interactive digital media. The patient reported that he or she received Shingles vaccine and still experience soreness arm. The patient stated that it was hurts to raise his or her right arm up to brush his or her hair or drive a car. The patient reported that the arm was sore as soon as the vaccine was administered. The patient received ibuprofen and held ice pack on arm as a treatment and it relieved some of soreness but not completely. Follow-up would not possible as no contact details were available. This case had been linked with US2023AMR067434 by same reporter for same patient.; Sender's Comments:  US-GSK-US2023AMR067434:Same reporter
Sex: U
Vaccine: VARZOS
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of pain in arm in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced pain in arm (Verbatim: Sore arm). The outcome of the pain in arm was resolved (duration 1 day).   It was unknown if the reporter considered the pain in arm to be related to Shingles vaccine.     It was unknown if the company considered the pain in arm to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-MAR-2023 This case was reported by the patient via  interactive digital media. The patient received Shingles vaccine and only side effect was a sore arm and that was the next day. The follow-up could not be possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster, Urticaria
Clinical narrative: Shingles; Hives; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced shingles (Verbatim: Shingles) and hives (Verbatim: Hives). The outcome of the shingles and hives were not reported.   It was unknown if the reporter considered the shingles and hives to be related to Shingles vaccine.   It was unknown if the company considered the shingles and hives to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-MAR-2023 This case was reported by a patient via interactive digital media. The patient took the shingles vaccine and broke out with shingles and hives.  So he/she could not take the second shingles shot. The follow up would not possible as no contact details were available.
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Shingles; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, immediately after receiving Shingles vaccine, the patient experienced shingles (Verbatim: Shingles). The outcome of the shingles was unknown.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.     It was unknown if the company considered the shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-Mar-2023. The patient reported this case via interactive digital media. The reporter stated that he/she know 2 people that got Shingles right after they got the Shingles shot.; Sender's Comments:  US-GSK-US2023AMR067378:Same reporter
Sex: U
Vaccine: VARZOS
Symptoms: Erythema, Hypersensitivity, Peripheral swelling, Pruritus, Swelling face
Clinical narrative: Severe allergic reaction; Arm swelled up; Red on deltoid; Itchy on deltoid; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of allergic reaction in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced allergic reaction (Verbatim: Severe allergic reaction), swelling arm (Verbatim: Arm swelled up), erythema of extremities (Verbatim: Red on deltoid) and itchy upper limbs (Verbatim: Itchy on deltoid). The outcome of the allergic reaction and swelling arm were not reported and the outcome of the erythema of extremities and itchy upper limbs were resolved (duration 1 month).   It was unknown if the reporter considered the allergic reaction, swelling arm, erythema of extremities and itchy upper limbs to be related to Shingles vaccine.     It was unknown if the company considered the allergic reaction, swelling arm, erythema of extremities and itchy upper limbs to be related to Shingles vaccine.   Linked case(s) involving the same patient:  US2023AMR067384   Additional Information: GSK Receipt Date: 31-MAR-2023 This case was reported by the patient via interactive digital media. The patient had severe allergic reaction, arm swelled up and was red and itchy on deltoid for a month. Second time the patient took Benadryl just in case.  When it worse off my face was swollen. Went immediately to get medical help.  The patient would not ever get another vaccine for this. The follow-up could not be possible as no contact details were available. For tolerance of 2nd dose refer case US2023AMR067384.; Sender's Comments:  US-GSK-US2023AMR067384:Same patient
Sex: U
Vaccine: VARZOS
Symptoms: Herpes zoster
Clinical narrative: Shingles; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of shingles in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, immediately after receiving Shingles vaccine, the patient experienced shingles (Verbatim: Shingles). The outcome of the shingles was not reported.   It was unknown if the reporter considered the shingles to be related to Shingles vaccine.     It was unknown if the company considered the shingles to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 31-Mar-2023. The patient reported this case via interactive digital media. The reporter stated that he/she know 2 people that got Shingles right after they got the Shingles shot. The follow-up would not possible as no contact details were available.; Sender's Comments:  US-GSK-US2023AMR067374:Same reporter